These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 9692834

  • 1. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.
    Tolnay E, Kuhnen C, Wiethege T, König JE, Voss B, Müller KM.
    J Cancer Res Clin Oncol; 1998; 124(6):291-6. PubMed ID: 9692834
    [Abstract] [Full Text] [Related]

  • 2. Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas.
    Thirkettle I, Harvey P, Hasleton PS, Ball RY, Warn RM.
    Histopathology; 2000 Jun; 36(6):522-8. PubMed ID: 10849094
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
    Harvey P, Warn A, Newman P, Perry LJ, Ball RY, Warn RM.
    J Pathol; 1996 Dec; 180(4):389-94. PubMed ID: 9014859
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K.
    Int J Cancer; 2010 Oct 15; 127(8):1948-57. PubMed ID: 20104519
    [Abstract] [Full Text] [Related]

  • 5. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors.
    Naim R, Tolnay E, Mueller KM, Kuhnen C.
    Int J Mol Med; 2004 Nov 15; 14(5):787-91. PubMed ID: 15492846
    [Abstract] [Full Text] [Related]

  • 6. Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma.
    König JE, Tolnay E, Wiethege T, Müller KM.
    Virchows Arch; 1999 Jul 15; 435(1):8-12. PubMed ID: 10431840
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor.
    Klominek J, Baskin B, Liu Z, Hauzenberger D.
    Int J Cancer; 1998 Apr 13; 76(2):240-9. PubMed ID: 9537587
    [Abstract] [Full Text] [Related]

  • 8. The role of the HGF/Met axis in mesothelioma.
    Thayaparan T, Spicer JF, Maher J.
    Biochem Soc Trans; 2016 Apr 15; 44(2):363-70. PubMed ID: 27068941
    [Abstract] [Full Text] [Related]

  • 9. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
    Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI.
    Br J Cancer; 1999 Sep 15; 81(1):54-61. PubMed ID: 10487612
    [Abstract] [Full Text] [Related]

  • 10. Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology.
    Harvey P, Warn A, Dobbin S, Arakaki N, Daikuhara Y, Jaurand MC, Warn RM.
    Br J Cancer; 1998 Apr 15; 77(7):1052-9. PubMed ID: 9569039
    [Abstract] [Full Text] [Related]

  • 11. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).
    To CT, Tsao MS.
    Oncol Rep; 1998 Apr 15; 5(5):1013-24. PubMed ID: 9683803
    [Abstract] [Full Text] [Related]

  • 12. Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma.
    Kuhnen C, Tolnay E, Steinau HU, Voss B, Müller KM.
    Virchows Arch; 1998 Apr 15; 432(4):337-42. PubMed ID: 9565343
    [Abstract] [Full Text] [Related]

  • 13. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas.
    Lamszus K, Laterra J, Westphal M, Rosen EM.
    Int J Dev Neurosci; 1999 Apr 15; 17(5-6):517-30. PubMed ID: 10571413
    [Abstract] [Full Text] [Related]

  • 14. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS, Weijer K, van den Berk PC, Muller EJ, Miranda N, Bakker AQ, Heemskerk MH, Hekman A, de Gast GC, Gerritsen WR.
    Br J Cancer; 1999 Sep 15; 81(1):43-53. PubMed ID: 10487611
    [Abstract] [Full Text] [Related]

  • 15. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY.
    Oncogene; 2007 Aug 16; 26(38):5577-86. PubMed ID: 17369861
    [Abstract] [Full Text] [Related]

  • 16. HGF/SF in angiogenesis.
    Rosen EM, Lamszus K, Laterra J, Polverini PJ, Rubin JS, Goldberg ID.
    Ciba Found Symp; 1997 Aug 16; 212():215-26; discussion 227-9. PubMed ID: 9524773
    [Abstract] [Full Text] [Related]

  • 17. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 18. Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla.
    Kajihara T, Ohnishi T, Arakaki N, Semba I, Daikuhara Y.
    Arch Oral Biol; 1999 Feb 15; 44(2):135-47. PubMed ID: 10206332
    [Abstract] [Full Text] [Related]

  • 19. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
    Moriyama T, Kataoka H, Koono M, Wakisaka S.
    Int J Mol Med; 1999 May 15; 3(5):531-6. PubMed ID: 10202187
    [Abstract] [Full Text] [Related]

  • 20. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.
    Abounader R, Laterra J.
    Neuro Oncol; 2005 Oct 15; 7(4):436-51. PubMed ID: 16212809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.